There were significant differences in age, body mass index, stroke severity, the level of white blood count, triglyceride, high density lipoprotein, alanine aminotransferase, and the proportion of DM, AF, stroke subtypes, prior antidiabetic agents, and the usage of antiplatelet drugs, statins, and hypoglycemic agents at discharge among these groups (p < .05). This evidence concerns the gene GPT and diabetes mellitus.